NCT06647368View on ClinicalTrials.gov

Development of a Non-invasive Method for Quantifying Cerebral Glucose Metabolism for Studying the Effect of Glucagon in Humans

NARecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

December 17, 2024

Study Completion Date

December 17, 2024

Conditions
Cerebral Glucose Metabolism
Interventions
OTHER

PET with 18-FDG

The intervention is a 1,5 hour PET scan, which will be performed in three steps (heart scan, brain scan and heart scan) and administration of radioactively labelled glucose (18-FDG) in two doses.

Trial Locations (1)

2400

RECRUITING

Department of Physiology and Nuclear Medicine, University of Copenhagen - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, Copenhagen

All Listed Sponsors
collaborator

Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark

UNKNOWN

lead

Nicolai Jacob Wewer Albrechtsen

OTHER